Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    1(100%)

    Phase Distribution

    Early Phase 1
    1
    100%

    Phase Distribution

    1

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution1 total trials
    Early Phase 1First-in-human
    1(100.0%)

    Highest Phase Reached

    Early Phase 1

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 0 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    1

    all time

    Status Distribution
    Active(1)

    Detailed Status

    Active, not recruiting1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    1
    Active
    1
    Success Rate
    N/A
    Most Advanced
    Early Phase 1

    Trials by Phase

    Early Phase 11 (100.0%)

    Trials by Status

    active_not_recruiting1100%

    Recent Activity

    1 active trials
    Showing 1 of 1
    active_not_recruitingearly_phase_1

    Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)

    NCT00737399

    Clinical Trials (1)

    Showing 1 of 1 trials
    NCT00737399Early Phase 1

    Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)

    Active Not Recruiting

    All 1 trials loaded

    Drug Details

    Intervention Type
    Behavioral
    Total Trials
    1